Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Pfizer shares fell 1% in after-hours trading

Pfizer shares fell 1% in after-hours trading

老虎证券老虎证券2026/06/22 20:57
Show original
Previously, the company announced the Phase III clinical trial results for its drug Sigvotatug Vedotin, which showed that the drug failed to significantly improve overall survival in patients. This outcome delivered a setback to Pfizer’s highly anticipated oncology pipeline. The market reacted promptly to this news, testing investor confidence. The stock price volatility reflected the market’s heightened sensitivity to R&D progress and a reassessment of future revenue potential. Despite this setback, Pfizer’s overall R&D pipeline remains extensive. The company stated it will continue to advance other ongoing projects. However, the failure of this key study undoubtedly adds uncertainty to the competitive landscape in the related field and underscores the inherent high risks of new drug development.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Elon Musk changes his stance! Tesla (TSLA.US) delays Cybertruck production halt to late summer 2027, just two days after suggesting “refund deposits”

Elon Musk stated that Cybertruck production will be extended until late summer 2027 to clear the order backlog, and Tesla's stock price rose by about 4%.

智通财经•2026/11/12 03:52
Elon Musk changes his stance! Tesla (TSLA.US) delays Cybertruck production halt to late summer 2027, just two days after suggesting “refund deposits”

Japanese dovish policymaker urges "slow down": Price increases are not driven by demand, rate hikes may drag down the economy and inflation

Toichiro Asada, a member of the Bank of Japan's Policy Board, stated that the central bank needs to remain cautious and closely monitor the impact of rate hikes on the economy, as rising interest rates pose the risk of suppressing the inflation trend.

智通财经•2026/11/12 03:18
Japanese dovish policymaker urges "slow down": Price increases are not driven by demand, rate hikes may drag down the economy and inflation

Don't Be Misled by "Instant Purchase, Instant Access": Pro Series Zero Wait Has Been the Norm for Years, UBS Maintains Apple (AAPL.US) Target Price at $340

The waiting time for iPhone 18 Pro is approaching zero, and Duo deliveries are scheduled until the end of January. UBS maintains its forecast for iPhone revenue in the December quarter at $95.1 billions, representing a year-on-year increase of 11.5%.

智通财经•2026/11/12 03:11
Don't Be Misled by "Instant Purchase, Instant Access": Pro Series Zero Wait Has Been the Norm for Years, UBS Maintains Apple (AAPL.US) Target Price at $340